MedTrace Logo

Renal Denervation in Patients With Refractory Hypertension

NCT00483808 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2013-11-05

No results posted yet for this study

Summary

To investigate the clinical utility of renal denervation in the treatment of refractory hypertension.

Conditions

Interventions

DEVICE

Ardian Symplicity™ Catheter

Renal denervation using the Symplicity Catheter

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Henry Krum, MBBS,PhD · The Alfred Hospital and Monash University, Melbourne, VIC, Australia

  • Robert Whitbourn, MBBS, FRACP · St. Vincent's Hospital, Fitzroy, VIC, Australia

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Australia
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483808 on ClinicalTrials.gov